1803 related articles for article (PubMed ID: 12341093)
21. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
22. The pill and cancer--IPPF response.
IPPF Med Bull; 1983 Dec; 17(6):1-2. PubMed ID: 12279693
[TBL] [Abstract][Full Text] [Related]
23. Dispelling OC myths and misperceptions.
Grimes DA
Dialogues Contracept; 1994; 4(3):1-4. PubMed ID: 12345574
[TBL] [Abstract][Full Text] [Related]
24. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
25. Oral contraceptives have beneficial effects.
PIACT Prod News; 1982 Aug; 4(2):1, 4. PubMed ID: 12311600
[TBL] [Abstract][Full Text] [Related]
26. The myth about contraceptives and breast cancer.
Ibekwe J
Dly Times; 1993 Mar; ():7. PubMed ID: 12179509
[TBL] [Abstract][Full Text] [Related]
27. [Oral contraceptives: recent safety studies (author's transl)].
Edgren RA
Contracept Fertil Sex (Paris); 1983 Sep; 11(9):975-83. PubMed ID: 12279633
[TBL] [Abstract][Full Text] [Related]
28. Statement on steroidal oral contraceptives.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1981 Dec; 15(6):3-5. PubMed ID: 12263973
[TBL] [Abstract][Full Text] [Related]
29. Weighing risks against benefits in contraceptive safety.
Akhter HH
Draper Fund Rep; 1983 Aug; (12):20-2. PubMed ID: 12338977
[TBL] [Abstract][Full Text] [Related]
30. Oral contraceptives and cancer of the reproductive organs.
Huezo C
IPPF Med Bull; 1985 Dec; 19(6):3-4. PubMed ID: 12267511
[TBL] [Abstract][Full Text] [Related]
31. [Vascular disease and hormonal treatment--epidemiology].
Vessey MP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
[TBL] [Abstract][Full Text] [Related]
32. Weighing the evidence on the pill and breast cancer.
Johnson JH
Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
[TBL] [Abstract][Full Text] [Related]
33. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation.
Rosenberg MJ; Waugh MS; Burnhill MS
Fam Plann Perspect; 1998; 30(2):89-92, 104. PubMed ID: 9561874
[TBL] [Abstract][Full Text] [Related]
34. Attitudes, regulations hinder use of the pill.
Townsend S
Netw Res Triangle Park N C; 1993 Mar; 13(3):6-10. PubMed ID: 12318101
[TBL] [Abstract][Full Text] [Related]
35. The pill: an evaluation of recent studies.
Rosenfield A
Johns Hopkins Med J; 1982 May; 150(5):177-80. PubMed ID: 7043036
[TBL] [Abstract][Full Text] [Related]
36. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
Kay CR
Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
[TBL] [Abstract][Full Text] [Related]
37. Non-Rx pills not health risks, study finds.
Soc Mark Forum; 1984; 1(4):7. PubMed ID: 12266335
[TBL] [Abstract][Full Text] [Related]
38. [Disease and contraception. Recent aspects].
Rozenbaum H
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):431-6. PubMed ID: 12280211
[TBL] [Abstract][Full Text] [Related]
39. [Choosing contraception for adolescents].
Wemeau-jacquemont C
NPN Med; 1985 Feb; 5(84):185-9. PubMed ID: 12280585
[TBL] [Abstract][Full Text] [Related]
40. [Oral contraception and carbohydrate metabolism: III--practical implications].
Hilal M
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):59-62. PubMed ID: 12341242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
